C124H121ClFN33O6 — CID 160580991
N-[3-[6-(3-chloro-4-fluorophenyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;(Z)-N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]-3-pyridin-3-ylprop-2-enamide;N-[1-[4-(2,2-dimethylpropyl)pyrimidin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[1-[6-(2,2-dimethylpropyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-[(2R)-2-phenylpropyl]pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide (PubChem CID 160580991) has the molecular formula C124H121ClFN33O6 and a molecular weight of 2224.01 g/mol. Its IUPAC name is N-[3-[6-(3-chloro-4-fluorophenyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;(Z)-N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]-3-pyridin-3-ylprop-2-enamide;N-[1-[4-(2,2-dimethylpropyl)pyrimidin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[1-[6-(2,2-dimethylpropyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-[(2R)-2-phenylpropyl]pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide.
| Compound Name | N-[3-[6-(3-chloro-4-fluorophenyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;(Z)-N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]-3-pyridin-3-ylprop-2-enamide;N-[1-[4-(2,2-dimethylpropyl)pyrimidin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[1-[6-(2,2-dimethylpropyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-[(2R)-2-phenylpropyl]pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide |
|---|---|
| PubChem CID | 160580991 |
| Molecular Formula | C124H121ClFN33O6 |
| Molecular Weight | 2224.01 g/mol |
| Exact Mass | 2221.99 |
| IUPAC Name | N-[3-[6-(3-chloro-4-fluorophenyl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;(Z)-N-[3-[6-(2,2-dimethylpropyl)pyrazin-2-yl]benzimidazol-5-yl]-3-pyridin-3-ylprop-2-enamide;N-[1-[4-(2,2-dimethylpropyl)pyrimidin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[1-[6-(2,2-dimethylpropyl)pyrimidin-4-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-(4-methylpiperazin-1-yl)pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide;N-[3-[6-[(2R)-2-phenylpropyl]pyrazin-2-yl]benzimidazol-5-yl]prop-2-enamide |
| SMILES | C=CC(=O)Nc1ccc2c(c1)ncn2-c1cc(CC(C)(C)C)ncn1.C=CC(=O)Nc1ccc2c(c1)ncn2-c1nccc(CC(C)(C)C)n1.C=CC(=O)Nc1ccc2ncn(-c3cncc(-c4ccc(F)c(Cl)c4)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(C[C@@H](C)c4ccccc4)n3)c2c1.C=CC(=O)Nc1ccc2ncn(-c3cncc(N4CCN(C)CC4)n3)c2c1.CC(C)(C)Cc1cncc(-n2cnc3ccc(NC(=O)/C=C\c4cccnc4)cc32)n1 |
| InChI | InChI=1S/C24H24N6O.C23H21N5O.C20H13ClFN5O.C19H21N7O.2C19H21N5O/c1-24(2,3)12-19-14-26-15-22(28-19)30-16-27-20-8-7-18(11-21(20)30)29-23(31)9-6-17-5-4-10-25-13-17;1-3-23(29)27-18-9-10-20-21(12-18)28(15-25-20)22-14-24-13-19(26-22)11-16(2)17-7-5-4-6-8-17;1-2-20(28)25-13-4-6-16-18(8-13)27(11-24-16)19-10-23-9-17(26-19)12-3-5-15(22)14(21)7-12;1-3-19(27)22-14-4-5-15-16(10-14)26(13-21-15)18-12-20-11-17(23-18)25-8-6-24(2)7-9-25;1-5-18(25)23-13-6-7-16-15(8-13)22-12-24(16)17-9-14(20-11-21-17)10-19(2,3)4;1-5-17(25)22-13-6-7-16-15(10-13)21-12-24(16)18-20-9-8-14(23-18)11-19(2,3)4/h4-11,13-16H,12H2,1-3H3,(H,29,31);3-10,12-16H,1,11H2,2H3,(H,27,29);2-11H,1H2,(H,25,28);3-5,10-13H,1,6-9H2,2H3,(H,22,27);5-9,11-12H,1,10H2,2-4H3,(H,23,25);5-10,12H,1,11H2,2-4H3,(H,22,25)/b9-6-;;;;;/t;16-;;;;/m.1..../s1 |
| InChIKey | RBTXMNWRQVCSIN-LTEZQUQGSA-N |
| XLogP | 21.89 |
| TPSA | 455.57 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 165 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2224.01 |
| LogP ≤ 5 | 21.89 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 33 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|